Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping

Overview of attention for article published in Annals of Surgical Oncology, October 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 6 X users

patent: 1 patent

Citations

dimensions_citation: 62 Dimensions

Readers on

mendeley: 115 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

ENDOCRINE TREATMENT OF HORMONE RECEPTOR POSITIVE BREAST CANCER TYPED AS HAVING A LOW RISK…

Application WO-2022235163-A1

World Intellectual Property Organisation (WIPO)